Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL04
- Pharmacological subgroupL04A
- Chemical subgroupL04AG
- Chemical substanceL04AG08Ocrelizumab
Where it is registered
Each register with its number of medicines and a few of them.
Spain
AEMPS · 2 medicines
Netherlands
CBG-MEB · 2 medicines



